| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 36.31B | 36.22B | 33.18B | 30.11B | 23.70B |
| Gross Profit | 4.44B | 4.70B | 4.81B | 4.23B | 4.02B |
| EBITDA | 1.97B | 2.52B | 3.68B | 2.89B | 2.73B |
| Net Income | 676.58M | 1.15B | 1.95B | 1.51B | 1.67B |
Balance Sheet | |||||
| Total Assets | 37.06B | 38.61B | 39.38B | 36.96B | 28.78B |
| Cash, Cash Equivalents and Short-Term Investments | 12.09B | 14.13B | 15.75B | 13.37B | 6.93B |
| Total Debt | 273.65M | 335.96M | 351.36M | 233.54M | 266.13M |
| Total Liabilities | 21.62B | 21.45B | 21.16B | 19.96B | 18.47B |
| Stockholders Equity | 14.60B | 16.42B | 17.61B | 16.46B | 9.89B |
Cash Flow | |||||
| Free Cash Flow | 1.53B | 1.48B | 2.22B | 2.30B | 2.56B |
| Operating Cash Flow | 1.69B | 1.92B | 2.59B | 2.76B | 2.83B |
| Investing Cash Flow | -1.04B | -898.66M | 152.40M | -36.49M | 518.93M |
| Financing Cash Flow | -3.01B | -3.16B | -516.83M | 4.18B | -2.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$17.06B | 6.11 | 15.06% | 4.43% | 4.84% | 4.54% | |
71 Outperform | HK$14.00B | 15.46 | 11.18% | 2.78% | 6.95% | 28.21% | |
69 Neutral | HK$13.04B | 10.01 | 23.68% | 3.82% | 6.94% | -9.60% | |
66 Neutral | HK$19.90B | 30.82 | 1.68% | 4.94% | 9.98% | -68.38% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
62 Neutral | HK$14.59B | 11.52 | 74.40% | ― | 6.46% | -3.32% | |
61 Neutral | HK$19.72B | 28.27 | 4.63% | 1.77% | 2.94% | -39.39% |